Fulgent Genetics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
281.98 |
310.70 |
343.21 |
376.02 |
| Przychód Δ r/r |
0.00% |
10.18% |
10.46% |
9.56% |
| Przychód (min) |
279.61 |
299.53 |
340.16 |
375.96 |
| Przychód (max) |
284.35 |
321.87 |
345.87 |
376.08 |
| EBITDA (średnia) |
79.60 |
87.70 |
96.88 |
106.14 |
| EBIT (średnia) |
65.15 |
71.79 |
79.30 |
86.88 |
| EBIT % |
23.11% |
23.11% |
23.11% |
23.11% |
| Zysk netto (średni) |
9.69 |
-16.68 |
-17.26 |
-11.67 |
| Zysk netto % |
3.44% |
-5.37% |
-5.03% |
-3.10% |
| EPS (średnia) |
0.33 |
-0.55 |
-0.63 |
-0.39 |
| Liczba analityków (Przychody) |
2 |
2 |
3 |
3 |
| Liczba analityków (EPS) |
1 |
2 |
2 |
2 |
| symbol |
FLGT |
FLGT |
FLGT |
FLGT |